Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Myasthenia Gravis 4 Carcinoma, Hepatocellular 2 Skin Neoplasms 1 Nervous System Diseases 1 Melanoma 1 Hepatitis 1 Colitis 1 Autoimmune Diseases 1 Arthritis, Rheumatoid 1

Interventions

Infliximab 4 vedolizumab 3 Fecal Microbiota Transplantation 3 Prednisone 2 Methylprednisolone 2 LDP-02 2 Immunoglobulin G 2 Disulfides 2 CT-P13 2 tocilizumab 1 prednylidene 1 fish oil triglycerides 1 deltacortene 1 Standard of Care 1 Practice Guidelines as Topic 1 Photopheresis 1 Mycophenolic Acid 1 Methylprednisolone Hemisuccinate 1 Methoxsalen 1 Loperamide 1 Injections 1 Endoscopy 1 Diagnosis 1 Colonoscopy 1 Cell- and Tissue-Based Therapy 1 Azathioprine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Colitis × Azathioprine × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡